IPOs

Gilead-partnered Vienna-based immunotherapy company Hookipa makes Nasdaq debut with downsized $84M IPO
Gilead-partnered Vienna-based immunotherapy company Hookipa makes Nasdaq debut with downsized $84M IPO
Endpoints
Hookipa
Gilead Sciences
IPOs
Flag link:
KCI Files for $100 Million IPO
KCI Files for $100 Million IPO
CP Wire
KCI
devices
wound care
IPOs
Flag link:
KCI Files for $100 Million IPO
KCI
medical devices
IPOs
Flag link:
Four biotech Nasdaq wannabes outline IPO plans — and don't miss Chi-Med's HKEX pitch
Four biotech Nasdaq wannabes outline IPO plans — and don't miss Chi-Med's HKEX pitch
Endpoints
biotech
IPOs
NASDAQ
NextCure
Applied Therapeutics
Cortexyme
Chi Med
Milestone Pharmaceuticals
Flag link:
Clinical-Stage Neurodegenerative Disease Company Files for $86 Million IPO
Clinical-Stage Neurodegenerative Disease Company Files for $86 Million IPO
CP Wire
Cortexyme
IPOs
COR388
Alzheimer's disease
Flag link:
Clinical-Stage Neurodegenerative Disease Company Files for $86 Million IPO
Cortexyme
IPOs
COR388
Alzheimer's disease
Flag link:
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Wave Life Sciences
Sarepta Therapeutics
Novavax
ContraFect
Scynexis
earnings
Abbott Labs
Intuitive Surgical
Brainsway
Hookipa
Turning Point Therapeutics
IPOs
Flag link:
This Chinese pharma filed for an IPO last September. Seven months and a $283M investment later, they are back at the HKEX
This Chinese pharma filed for an IPO last September. Seven months and a $283M investment later, they are back at the HKEX
Endpoints
Hansoh Pharmaceutical
China
IPOs
Hong Kong
Flag link:
5 things to know about Hookipa Pharma ahead of its IPO
5 things to know about Hookipa Pharma ahead of its IPO
Marketwatch
Hookipa
IPOs
cancer
infectious diseases
Flag link:
Axcella Health Files for $86 Million IPO
Axcella Health Files for $86 Million IPO
CP Wire
Axcella Health
IPOs
hepatic encephalopathy
AXA1665
Flag link:
Axcella Health Files for $86 Million IPO
Axcella Health
IPOs
hepatic encephalopathy
AXA1665
Flag link:
Trevi Therapeutics jumps on the biotech IPO train
Trevi Therapeutics jumps on the biotech IPO train
Fierce Biotech
IPOs
Trevi Therapeutics
idiopathic pulmonary fibrosis
levodopa-induced dyskinesia
chronic pruritus
Flag link:
Turning Point Therapeutics Updates Its IPO Filing – Will Raise Up to $152 Million
Turning Point Therapeutics Updates Its IPO Filing – Will Raise Up to $152 Million
CP Wire
IPOs
Turning Point Therapeutics
Flag link:
Turning Point Therapeutics Updates Its IPO Filing – Will Raise Up to $152 Million
Turning Point Therapeutics
IPOs
Flag link:
Brainsway sets terms for $30m IPO
Brainsway sets terms for $30m IPO
Mass Device
Brainsway
IPOs
devices
transcranial magnetic stimulation
Flag link:
NGM Bio’s IPO Raises $107M as NASH Drug Continues Clinical Testing
NGM Bio’s IPO Raises $107M as NASH Drug Continues Clinical Testing
Xconomy
NGM Biopharmaceuticals
IPOs
Merck
Flag link:
Silk Road Medical Looks Upward – Raises IPO Target to $138 Million
Silk Road Medical Looks Upward – Raises IPO Target to $138 Million
CP Wire
Silk Road Medical
IPOs
TCAR
Flag link:
Precision BioSciences Exceeds Expectations with IPO
Precision BioSciences Exceeds Expectations with IPO
CP Wire
Precision Biosciences
IPOs
Gilead Sciences
Flag link:
Precision BioSciences Exceeds Expectations with IPO
Precision Biosciences
IPOs
Gilead Sciences
Flag link:
March Madness: "The Fabulous 5" Life Science IPOs
March Madness: "The Fabulous 5" Life Science IPOs
BioSpace
IPOs
Genfit
Silk Road Medical
NGM Biopharmaceuticals
Precision Biosciences
Shockwave Medical
Flag link:

Pages